Texas Administrative Code
Title 26 - HEALTH AND HUMAN SERVICES
Part 1 - HEALTH AND HUMAN SERVICES COMMISSION
Chapter 261 - INTERMEDIATE CARE FACILITIES FOR INDIVIDUALS WITH AN INTELLECTUAL DISABILITY OR RELATED CONDITIONS (ICF/IID) PROGRAM-CONTRACTING
Subchapter J - SURROGATE DECISION-MAKING
Section 261.285 - IDT Decisions
Universal Citation: 26 TX Admin Code ยง 261.285
Current through Reg. 49, No. 38; September 20, 2024
(a) An IDT may:
(1) consent to the following changes
regarding administration of a psychoactive medication subsequent to the initial
consent for the medication given by a surrogate consent committee, if such
changes pose no significant risk to an individual based on the judgment of the
prescribing health care professional and other health care professionals
involved in the individual's care:
(A) an
increase or decrease in the dosage of the medication; and
(B) a change of medication within the same
therapeutic drug class; and
(2) make a decision that involves risk to the
individual protection and rights not specifically reserved to a surrogate
decision-maker or a surrogate consent committee.
(b) An IDT's consent to a change regarding the administration of a psychoactive medication, as described in subsection (a)(1) of this section, is only valid until the expiration of the initial consent by the surrogate consent committee.
(c) The IDT must document, in the individual's record, a decision made in accordance with subsection (a) of this section, including the deliberations of the IDT in reaching the decision.
Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
